Fig. 3.
Kaplan–Meier drug survival curves at 12 months for individual biologics: ADA adalimumab, CER certolizumab pegol, ETA etanercept, GOL golimumab, INF infliximab, SEC secukinumab, UST ustekinumab
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.